NF-κB is an active player in cancer cell proliferation, which allowed us to evaluate the effect of Nrf2 knockdown on the NF-κB signaling pathway in CyCl-treated colon cancer cells. The gene discussed is NFE2L2; the disease is colonic neoplasm.